{"name":"Qlaris Bio, Inc.","slug":"qlaris-bio-inc","ticker":"","exchange":"","domain":"qlarisbio.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxQbk91SWw5cmEtMzhiRXhJNmRsVnpBaWhfcXg0T0h5Szh4Tm1zSGk0V1h1emxUcVRmaVgyczdpM1ZXXzJFYVBvWXRuNGpXckd1NjJzWmU0ZVFNMmpJSFl6dTFDR0I3Zzk0VURWZmo0bGl1Zl9hbHhOY1k3elhSNXlXM09HeDlMNk5mSFlZajQxSDctOGl5c0ZtYm9fbnZ6aEU?oc=5","date":"2026-04-03","type":"earnings","source":"openPR.com","summary":"Open Angle Glaucoma Market: Expanding Revenue Landscape to 2034 - openPR.com","headline":"Open Angle Glaucoma Market: Expanding Revenue Landscape to 2034","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6gFBVV95cUxNeFVfZ1F2LWFobnBLNENTMHJUZ2tTUkMtT2JTSXNlOG04NHdlbDN0c2dWcldFaWYzakxuNjRnc0Q1TWJ1VndOSWVhblpUazd1bGhXbGhxUWhRNi1HZVpHalBJbVc0QVRhMXVjSlMtdHJHUEdmME1OcTktb0tDUEY5OXVWZU1sQ1NxYURrUWdEYzZucjVDNmJjZXZhOGRjMUxVMEc4RHFsMGF1SEl4NVMwdTk3NEt1SW1kWkpEb2UwbHRWbVpNbHRiNmhnWlBXVkJxeWR1SWZ4a0k1UlZ5dmpSWllSU29tSU92NXc?oc=5","date":"2026-03-24","type":"pipeline","source":"Barchart.com","summary":"Ocular Hypertension Pipeline Demonstrates Strong Momentum with 50+ Companies Advancing 75+ Therapies | DelveInsight - Barchart.com","headline":"Ocular Hypertension Pipeline Demonstrates Strong Momentum with 50+ Companies Advancing 75+ Therapies | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxPcG1Rd3FHb29JOGkwc01YZzVtQTV6MDRITTAwZi05ZkJhN3BlclBoNTJDUV9VWkUxMVJjS001WkJxZUZQSzVmeEhkT19kR25ZbE9XOEd1Y1ZXbzRRai1lUzRvT3J6NXNISE1UcVBMUGt2LWpyUGhsZ0ZUNjV1WlhnendlZ0RZM2FUeWVFMUlkUGY3aTJO?oc=5","date":"2026-03-18","type":"pipeline","source":"Pharmafile","summary":"Qlaris Bio appoints Fred Guerard as President and CEO - Pharmafile","headline":"Qlaris Bio appoints Fred Guerard as President and CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxOSHJUZF9UaWxjdFJtYlJjWGJZRlBMaWhnMEZGenViY2JwQ0F5d09KaGs3bXQ0clBiR2FJaUlsVHVCTUtWSVpHUTZBcjA5em5tRVF1dnQwOWZFeXZSQ2NFU3ZQT29ISE8yMGNWbG9qaHRYNHVPel95TVlweGtvVElXZ1dqMkpmbzRHR1daZFJ0OEcwVlV2ZXltTTZnQWZVWDkwV2hHSw?oc=5","date":"2026-03-13","type":"pipeline","source":"Fierce Biotech","summary":"BioNTech founders to pioneer new company—Chutes & Ladders - Fierce Biotech","headline":"BioNTech founders to pioneer new company—Chutes & Ladders","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxNZm11OHR6aDZ1UFhZT2dMT1VtV096NHBNRGVaZHpDM0VnUVhlajhtM1I4cXZFeC1uVHIxalZIYV9LMGNfTjBGLUg0ZHkzTDB6OHQ4Y0U2eC0zdmViS2FGb1F3OWNTdWhOdG8yVDR5ckR6NUZob2FKTDZwdjA4UndoXzZ2LUhTSDBFempqdkR0N3o0Ujc1ckQ1dzJoNW9pZGRPOS1PWlFZd2VSXzJ6OENpdGtn?oc=5","date":"2026-03-13","type":"trial","source":"endpoints.news","summary":"Flagship startup loses CEO to Ipsen; Ionis to shed nearly six decades of board experience - endpoints.news","headline":"Flagship startup loses CEO to Ipsen; Ionis to shed nearly six decades of board experience","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxPOU0zZ1M2NGhIU3hqZ2dDNmJpcVJzYzgtVGRNT0dBTk1WNG9kVGV6Mk5rZjNqc3MtdEZLdHp3eE1lR0RnX1AxU3NLSlpPRE9Gc2FCMEtpQkdBc3FfMEllVnBKZ3JkdUFrUGxsQ29IeXVsTXczUkkwOE9GaUVxSVF1aThGS2hLWll2d1BOM3hBM2RaWVRra09ZNS10WlJMQjE2TWluSzVFSm1NSlJidHdrVTlscjJQZlBEVTdSdURoS0FHbTVrRnNzTzFrd3FZNjFCWVY0Q3V3?oc=5","date":"2026-03-10","type":"pipeline","source":"businesswire.com","summary":"Qlaris Bio Appoints Fred Guerard, Pharm.D., as President and Chief Executive Officer - businesswire.com","headline":"Qlaris Bio Appoints Fred Guerard, Pharm.D., as President and Chief Executive Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxQTlZrZGthMU5ldFpJTEs4LUgycTBEZGdlTWd3T2x5UmNFcFM4aVhOemFWX3RzOXB1N0kxR2ZQaWlIR1pIRU4ycE1SZU5HVGtxc01NMUFFSXNrdGRwY2JDTTY3ZGlWajA4d3pLYmRqaldUMFFqRXJ3UmRxcGNMQjlnVUlkTFJpcHp3UGRJU3NKS1pkTlFSZ3RfQ2czNlhsQQ?oc=5","date":"2026-01-29","type":"pipeline","source":"VisionMonday.com","summary":"Qlaris Bio Adds Robert Warner to Board of Directors - VisionMonday.com","headline":"Qlaris Bio Adds Robert Warner to Board of Directors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9wFBVV95cUxOTlQzRkpQQlZDZXVlTFU3RzJWVV9HN3RhdWxyQ1gxdGJDaHFvZWpFQy1tOWRDbXhESDk2RkVWajdQZ2NhSTFncGlxTF9WTEVXMTdYZlhWdmd6NVI3b1FTbGdCZjNGTXBrVWp3S19GUF9DZlh0OFF3RXI0cU1XMFZhVXFzZjJZVkNpUU95bm9Jc0Y3Sm9yMkFoQ1dTTzNPb29PY0MwZ2VWaXJNR3d0WHgtY1BXV0FFWlMzZFRwdGl6VmR5U2xGMUNSLTRLdm9UQ2p6dVlvYU1BemYySTVLTE5va3ZFdmxvb0thRXNUNzlCVWJld0VuUDZn?oc=5","date":"2025-09-09","type":"pipeline","source":"PR Newswire","summary":"Open-Angle Glaucoma Market Outlook Brightens as Emerging Therapies Reshape Treatment Paradigms | DelveInsight - PR Newswire","headline":"Open-Angle Glaucoma Market Outlook Brightens as Emerging Therapies Reshape Treatment Paradigms | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxPZFhZWjdGOUotREpTZy1CR0tQcmJUWVZKTUVWQkw1aVBONkpVaE1DckZRWk9ldFNSLWpOWXl3bmxSTVlpNlQ1YVItS0JWMUlSTGVhSE01dks3aG53UjIxcHhNRFJ6dDV4UEE5S0hkUkNJOG84Mldfc2VnYjRaYjlzRjBwSWlHU0d0X2VDcWpIUEJNMzFyZHpFRFV2b0M0SU1GTXl2SHRSSEhXWi1GWi1aSGh1OHlQUkhOYXBMd3JWeGxnVTViOFRDLVpCUQ?oc=5","date":"2025-06-11","type":"pipeline","source":"Eyes On Eyecare","summary":"Qlaris Bio developing fixed-dose latanoprost and QLS-111 eye drop for glaucoma - Eyes On Eyecare","headline":"Qlaris Bio developing fixed-dose latanoprost and QLS-111 eye drop for glaucoma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-wFBVV95cUxNeGh0c3VweFFnWmVnRkFPQ3JtTnFRWXBMbFYxdVdvR0ltWlBqV3BHZnczVFZfaVc1V0NBY3l3WDU3dW55TkZhQTVtV082RFFjRU1MYlEzcFBnN1NiNUJLa2U3empwZ3NVZklCb1ZsY0RWQ2U1WFRBSktRZXljWFFLWkQtQTNQVUNHY2puQkhVYUdUMWhTQzhYQXFJbFdJMEhIMkVsVkZ0ZldPa2cwMWdEOW1IQUN4N2lCMXg3bUJSTXRzWV9mb1FpaklQMGphUmVxNWtlRzRiUmN0UjZUd0VRalBfaDRiOE5aWnhucTVsaWdCamdSUEQ5SzBWYw?oc=5","date":"2025-05-15","type":"pipeline","source":"GlobeNewswire","summary":"Global Intraocular Lens Market to Witness Upsurge in Growth at a CAGR of ~5% by 2032 | DelveInsight - GlobeNewswire","headline":"Global Intraocular Lens Market to Witness Upsurge in Growth at a CAGR of ~5% by 2032 | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgJBVV95cUxQQ2FEaDVsQnNKbkxyRnAyVFNIOFVObTdPRVJ0aTVmTG16WnR1VXNHajZrOXBiYjJpRk4tb29fRnNZRmprS1g4dFlqMlNFbXNDR1J2N0VYVURsU2RKcjdCMEw5V2xLYlU5V2RXbGFxSmhKcm9oeWUwdUtlNzFYQ2ZjaTlhS1huTXRGdHdlTHRad3hvRlVnOG5LLTdscHBFc3lfSnUtWG5hNGpOcjdOS2RNLXNYOG1YZC1XbnZjaG9uVkJnOHFOb3g3a3FtbHBEcTJjZFFQNWp3M1NLRDhJR1ZESFJfUlp3MV9CVzM1RDBkTWNRM29VQkFxaTJMOENvZDVVb0VoNXZEREg5RFlYLWdYSDRjSWN4dw?oc=5","date":"2025-02-05","type":"trial","source":"BioSpace","summary":"Qlaris Bio Announces Positive Topline Data From Two Phase II Trials of QLS-111 in Patients With Primary Open Angle Glaucoma and Ocular Hypertension - BioSpace","headline":"Qlaris Bio Announces Positive Topline Data From Two Phase II Trials of QLS-111 in Patients With Primary Open Angle Glauc","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxNYkNDdmt4czNDdk9XUGhSWVBXX05KUHlMREdPRHlXR1hqek8yZlRTa1VjTmlvT0xRYUtQcnoxUFgzZHVraEtVVWNMM3UwOGRuR3hac3BmaDFKaEJwVmFsQW1UZFZBSEItUnEwdFJkbWlESTF0SkJiNUhFZGdRa2lmNzF6cnRKUjNiMjRCWDRCNEJ5ejkzZFo4VXI5VzZZeFhJ?oc=5","date":"2025-02-05","type":"trial","source":"BioWorld News","summary":"Qlaris’ QLS-111 reduces eye pressure in two phase II trials - BioWorld News","headline":"Qlaris’ QLS-111 reduces eye pressure in two phase II trials","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}